Loading stock data…
EIKN
$9.68+0.07 (+0.68%)
Market ClosedLast close May 1
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$9.68
Potential Upside
5%
Whystock Fair Value$10.16
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs using a platform that permits precise characterization of protein interactions in living cel...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$628.01M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
36.89%
Volume
Today's trading volume
158,047
Recent News
Spotify upgraded, First Solar downgraded: Wall Street's top analyst calls
Spotify upgraded, First Solar downgraded: Wall Street's top analyst calls
Jennifer Garner’s Once Upon a Farm Rises Nearly 20% to Wrap Up Busy Week for IPOs
Jennifer Garner’s Sidney Bristow character from the TV show Alias and Elektra in Marvel movies may have faced formidable foes. Garner is a co-founder and investor in the organic baby food company Once Upon a Farm which began trading Friday after a rocky week for the market and initial public offerings. Once Upon a Farm priced the IPO at $18, the midpoint of its expected range.
This Mobile App Marketing Firm Is Holding Off an IPO for Now
Liftoff Mobile has postponed its initial public offering, citing market conditions after another day of sharp declines in stocks. “Given current market conditions, we have made a business decision to take additional time before listing,” the company said in a statement emailed to Barron’s. “We are encouraged by the strong interest and positive feedback we have received from investors.” Stocks of peer companies such as AppLovin and Unity Software have fallen along with the tech sector in recent weeks, pressured by concerns over how artificial intelligence is going to transform the industry.